Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors-Reference-Cited by-同舟云学术

Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors

Published:2016-04-14 Issue:4 Volume:11 Page:e0153411
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Norton Nadine,Advani Pooja P.,Serie Daniel J.,Geiger Xochiquetzal J.,Necela Brian M.,Axenfeld Bianca C.,Kachergus Jennifer M.,Feathers Ryan W.,Carr Jennifer M.,Crook Julia E.,Moreno-Aspitia Alvaro,Anastasiadis Panos Z.,Perez Edith A.,Thompson E. Aubrey

Funder

Mayo Clinic Cancer Focus Research Team

26.2 with Donna Foundation

Serene M. and Frances C. Durling endowment

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome;G Arpino;Breast Cancer Res,2004

2. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients;R Wolters;Breast Cancer Res Treat,2013

3. Tumor size and survival in multicentric and multifocal breast cancer;A Rezo;Breast,2011